Oramed Pharmaceuticals Inc (ORMP) — Cash Flow Quality Index
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow Quality Index of -0.04x as of September 2025. Operating cash flow of $-1.99 Million is below net income of $48.40 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Oramed Pharmaceuticals Inc (ORMP) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oramed Pharmaceuticals Inc Cash Flow Quality Index (2023–2025)
Historical Cash Flow Quality Index for Oramed Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ORMP intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Oramed Pharmaceuticals Inc (2023–2025)
Year-by-year earnings quality comparison for Oramed Pharmaceuticals Inc. For live market cap and the full company financial profile, see ORMP stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-9.14 Million | $64.02 Million | ▲ +92.3% |
| 2023 | -1.86x | $-10.29 Million | $5.53 Million | — |